Human IL-13 Platinum ELISA

Also known as: ALRH, BHR1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS231/3*

Cat. No. Size
BMS231/3 96 tests
BMS231/3TEN 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human IL-13 Platinum ELISA.

Click on image to view more information.

  • Data for Human IL-13 Platinum ELISA.
Description

Description: The human IL-13 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human IL-13. The human IL-13 ELISA is for in vitro diagnostic use. Not for use in therapeutic procedures.

Human IL-13 is a nonglycosylated protein of 132 amino acids with a molecular weight of 12 kDa. The IL-13 gene is located on chromosome 5q23-31, in the same region as the genes encoding IL-3, IL-4, IL-5 and GM-CSF. It is produced by activated CD4+ and CD8+ T cells, but the expression seems to be more abundant in CD4+ T cells. Although it is a Th2 cytokine in the mouse, it appears to be produced by Th0, Th1, and Th2-like human T cell clones.
IL-13 induces CD23 expression on B cells, promotes B cell proliferation in combination with anti-Ig or CD40 antibodies, and stimulates secretion IgE, and IgG4. IL-13 has also been shown to prolong survival of human monocytes and increases surface expression of MHC class II, CD23, and members of the integrin superfamily, like CD11b, CD11c, CD18, CD29 and CD49e. IL-13 inhibits the production of a series of cytokines like IL-1, IL-6, TNF-alpha, and IL-8 by activated human monocytes. IL-13 induces IFN-gamma production by NK cells.
The capacity of IL-13 to induce IgE synthesis indicates that IL-13 may play an important regulatory role in IgE-mediated atopic diseases. The measurement of IL-13 in body fluids may thus provide further information about the pathophysiology of atopic diseases.

Furthermore, IL-13 inhibits HIV-1 replication in primary culture-derived macrophages and represents a candidate cytokine for the suppression of HIV infection within monocytes and macrophages in vivo.

Details
Reactivity Human
Sample Volume 50 uL
Suitable Sample Types cell culture supernatant, serum, plasma (EDTA, citrate, heparin)
Sensitivity 0.7 pg/mL
Standard Curve Range 1.6 - 100 pg/mL
Components Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to human IL-13
Biotin-Conjugate anti-human IL-13 monoclonal antibody
Streptavidin-HRP
Human IL-13 Standard lyophilized, 200 pg/mL upon reconstitution
Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA)
Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Substrate Solution (tetramethyl-benzidine)
Stop Solution (1M Phosphoric acid)
Blue-Dye
Green-Dye
Adhesive Films
Reported Applications ELISA
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
References

Citations: Sun,Yong Jiang; Lim,T.K.; Ong,Adrian Kheng Yeow; Ho,Benjamin Choon Heng; Seah,Geok Teng; Paton,Nicholas I.. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infectious Diseases 2006;6:105(Link)

Silvestri,M.; Bontempelli,M.; Giacomelli,M.; Malerba,M.; Rossi,G.A.; Stefano,A.D.; Rossi,A.; Ricciardolo,F.L.M.. High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation?. Clinical & Experimental Allergy 2006;36:1373-1381. (Link)

Chen,R.F.; Liu,J.W.; Yeh,W.T.; Wang,L.; Chang,J.C.; Yu,H.R.; Cheng,J.T.; Yang,K.D.. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunology and Medical Microbiology 2005;44:43-50. (Link)

Yamada,Takashi; Sato,Akira; Komiya,Ichiro; Nishimori,Takeo; Ito,Yoshiharu; Terao,Akira; Eto,Sumiya; Tanaka,Yoshiya. An Elevation of Serum Immunoglobulin E Provides a New Aspect of Hyperthyroid Graves' Disease. Journal of Clinical Endocrinology & Metabolism 2000;85:2775-2778. (Link)

Kurosawa,M.; Inamura,H.; Amano,H.; Kanbe,N.; Nagata,H.; Nagai,H.; Furukawa,S.; Miyachi,Y.. Nerve growth factor release with mast-cell-derived mediators in a patient with systemic mastocytosis after middle-wave ultraviolet irradiation. Allergy 1999;54:994-998. (Link)

Pittoni,V.; Bombardieri,M.; Spinelli,F.R.; Scrivo,R.; Alessandri,C.; Conti,F.; Spadaro,A.; Valesini,G.. Anti-tumour necrosis factor (TNF) {alpha} treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Annals of the Rheumatic Diseases 2002;61:723-725. (Link)

Farkas,L.; Kvale,E.O.; Johansen,F.E.; Jahnsen,F.L.; Lund-Johansen,F.. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: Modulation by CpG oligodeoxynucleotides. Journal of Allergy and Clinical Immunology 2004;114:436-443. (Link)

ALEXEYEV,O.A.; LINDERHOLM,M.; ELGH,F.; WADELL,G.; JUTO,P.; TARNVIK,A.. Increased plasma levels of soluble CD23 in haemorrhagic fever with renal syndrome; relation to virus-specific IgE. Clinical and Experimental Immunology 1997;109:351-355. (Link)

Plath,K.E.S.; Grabbe,J.; Gibbs,B.F.. Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils. Clinical & Experimental Allergy 2003;33:342-350. (Link)

Chen,Rong Fu; Liu,Jien Wei; Yeh,Wen Ting; Wang,Lin; Chang,Jen Chieh; Yu,Hong Ren; Cheng,Jiin Tsuey; Yang,Kuender D.. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunology and Medical Microbiology 2005;44:43-50. (Link)

NOMURA,Naho; YOSHIKAWA,Takahiro; KAMOI,Hiroshi; KANAZAWA,Hiroshi; HIRATA,Kazuto; FUJIMOTO,Shigeo. Induced sputum analysis in asymptomatic young adults with bronchial hyperresponsiveness to methacholine. Respirology 2007;12:516-522. (Link)

WIESEMANN,E.; KLATT,J.; WENZEL,C.; HEIDENREICH,F.; WINDHAGEN,A.. Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis. Clinical and Experimental Immunology 2003;133:454-460. (Link)

Yeh,Wen Ting; Chen,Rong Fu; Wang,Lin; Liu,Jien Wei; Shaio,Men Fang; Yang,Kuender D.. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunology & Medical Microbiology 2006;48:84-90. (Link)

References: Brown,K.D.; Zurawski,S.M.; Mosmann,T.R.; Zurawski,G.. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J.Immunol. 1989;142:679-687. (Link)

Izuhara,K.. The role of interleukin-4 and interleukin-13 in the non-immunologic aspects of asthma pathogenesis. Clin.Chem.Lab Med. 2003;41:860-864. (Link)

Punnonen,J.; Aversa,G.; Cocks,B.G.; McKenzie,A.N.; Menon,S.; Zurawski,G.; de Waal,Malefyt R.; de Vries,J.E.. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc.Natl.Acad.Sci.U.S.A 1993;90:3730-3734. (Link)

Montaner,L.J.; Doyle,A.G.; Collin,M.; Herbein,G.; Illei,P.; James,W.; Minty,A.; Caput,D.; Ferrara,P.; Gordon,S.. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J.Exp.Med. 1993;178:743-747. (Link)

Minty,A.; Chalon,P.; Derocq,J.M.; Dumont,X.; Guillemot,J.C.; Kaghad,M.; Labit,C.; Leplatois,P.; Liauzun,P.; Miloux,B.; .. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-250. (Link)

McKenzie,A.N.; Culpepper,J.A.; de Waal,Malefyt R.; Briere,F.; Punnonen,J.; Aversa,G.; Sato,A.; Dang,W.; Cocks,B.G.; Menon,S.; .. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc.Natl.Acad.Sci.U.S.A 1993;90:3735-3739. (Link)

Izuhara,K.; Arima,K.; Yasunaga,S.. IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr.Drug Targets.Inflamm.Allergy 2002;1:263-269. (Link)

Izuhara,K.; Arima,K.; Kanaji,S.; Ohta,S.; Kanaji,T.. IL-13: a promising therapeutic target for bronchial asthma. Curr.Med.Chem. 2006;13:2291-2298. (Link)

Cocks,B.G.; de Waal,Malefyt R.; Galizzi,J.P.; de Vries,J.E.; Aversa,G.. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int.Immunol. 1993;5:657-663. (Link)

Belardelli,F.. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995;103:161-179. (Link)

de Vries,J.E.; Zurawski,G.. Immunoregulatory properties of IL-13: its potential role in atopic disease. Int.Arch.Allergy Immunol. 1995;106:175-179. (Link)

Zurawski,G.; de Vries,J.E.. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol.Today 1994;15:19-26. (Link)

de Waal,Malefyt R.; Figdor,C.G.; Huijbens,R.; Mohan-Peterson,S.; Bennett,B.; Culpepper,J.; Dang,W.; Zurawski,G.; de Vries,J.E.. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J.Immunol. 1993;151:6370-6381. (Link)

Finkelman,F.D.. Anaphylaxis: lessons from mouse models. J.Allergy Clin.Immunol. 2007;120:506-515. (Link)

Zurawski,G.; de Vries,J.E.. Interleukin 13 elicits a subset of the activities of its close relative interleukin 4. Stem Cells 1994;12:169-174. (Link)

Izuhara,K.; Arima,K.. Signal transduction of IL-13 and its role in the pathogenesis of bronchial asthma. Drug News Perspect. 2004;17:91-98. (Link)


View More Products

AntigensArea of BiologyCell TypeFormats